VPIM
XLRN

Vanguard Personalized Indexing Management’s Acceleron Pharma XLRN Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,906
Closed -$328K – 1132
2021
Q3 		$328K Sell
1,906
-1,960
-51% -$256K 0.03% 727
2021
Q2 		$485K Buy
+3,866
New +$488K 0.05% 497

Vanguard Personalized Indexing Management's XLRN Position: Q4 2021 in Review

Vanguard Personalized Indexing Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 1,906 shares — an estimated $328K sold.

Vanguard Personalized Indexing Management first reported a position in XLRN in Q2 2021 and held it in 2 quarters. The position peaked at $485K in Q2 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Vanguard Personalized Indexing Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 1,906 Acceleron Pharma shares in Q4 2021, an estimated $328K.
  • Vanguard Personalized Indexing Management first reported a position in Acceleron Pharma in Q2 2021 and held it in 2 quarters.
  • Vanguard Personalized Indexing Management's Acceleron Pharma position peaked at $485K in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Vanguard Personalized Indexing Management's 13F filing for Q4 2021, filed 23 Feb 2022.